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Abstract: Cardiac function is compromised by oxidative stress which occurs upon exposing the heart to ischemia reperfu-
sion (I/R) for a prolonged period. The reactive oxygen species (ROS) that are generated during I/R incur extensive dam-
age to the myocardium and result in subcellular organelle remodeling. The cardiac nucleus, glycocalyx, myofilaments, 
sarcoplasmic reticulum, sarcolemma, and mitochondria are affected by ROS during I/R injury. On the other hand, brief 
periods of ischemia followed by reperfusion, or ischemic preconditioning (IPC), have been shown to be cardioprotective 
against oxidative stress by attenuating the cellular damage and alterations of subcellular organelles caused by subsequent 
I/R injury. Endogenous defense mechanisms, such as antioxidant enzymes and heat shock proteins, are activated by IPC 
and thus prevent damage caused by oxidative stress. Although these cardioprotective effects of IPC against I/R injury are 
considered to be a consequence of changes in the redox state of cardiomyocytes, IPC is considered to promote the produc-
tion of NO which may protect subcellular organelles from the deleterious actions of oxidative stress. The article is in-
tended to focus on the I/R-induced oxidative damage to subcellular organelles and to highlight the cardioprotective effects 
of IPC. In addition, the actions of various endogenous cardioprotective interventions are discussed to illustrate that 
changes in the redox state due to IPC are cardioprotective against I/R injury to the heart.  
Keywords: Cardioprotection, ischemia-reperfusion injury, ischemic preconditioning, oxidative stress, reactive oxygen species, 
subcellular organelles.  
INTRODUCTION 
  Oxidative stress plays a role in a number of cardiovascu-
lar diseases including hypertension, cardiomyopathy, cardiac 
hypertrophy, heart failure, and ischemia-reperfusion injury 
(I/R) [1, 2]. The I/R phenomenon pertains to cell damage 
induced by reactive oxygen species (ROS) and is associated 
with the development of intracellular Ca
2+ overload as well 
as deleterious effects on subcellular organelles [1, 2], (see 
Fig. (1)). The increase in intracellular Ca
2+ due to I/R injury 
consequently triggers a variety of chemical reactions that 
further augment production of ROS [3]. The primary sources 
of oxidative stress in the heart are mitochondrial cyto-
chromes, as well as xanthine oxidoreductase, NAD(P)H oxi-
dase, and nitric oxide synthase (NOS) [4]. A positive feed-
back loop concerning “ROS-induced ROS release” has been 
proposed after observing that ROS associating with mito-
chondrial depolarization resulted in a further release of ROS 
from the mitochondria [5]. This release of ROS changes the 
intracellular environment from its original reducing state to 
oxidizing milieu signaling causing the eventual expiration of 
the cell [6]. In particular, during the ischemic phase the level 
of ROS is relatively low [7], however upon reperfusion of 
the ischemic heart, bursts of ROS have been observed using 
electron paramagnetic resonance spectroscopy, spin trap 
[alpha]-phenyl-N-tert-butylnitrone, and luminal-enhanced 
ter-butyl-initiated chemiluminesence [1].  
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Fig. (1). Subcellular organelles affected by oxidative stress induced 
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  Clinical procedures including angioplasty, thrombolytic 
therapy, coronary bypass surgery, and cardiac transplantation 
are considered to cause I/R injury where the ischemic insult 
is prolonged beyond a certain critical period [1]. It can also 
occur following the termination of an angina attack [1]. This 
large burst of ROS following reperfusion can decrease car-
diac function by inhibiting contractile activity [8], altering 
membrane permeability [9], and increasing cell death [10]. 
The damage caused by I/R injury can potentially be attenu-
ated by cardiac preconditioning, first observed in the canine 
myocardium [11]. This phenomenon has been extensively 
studied since its initial detection in 1986 and has been found 
to be instrumental in delaying myocardial necrosis and re-
duce cell apoptosis, diminishing I/R-induced ventricular ar-
rhythmias, preserving post-ischemic endothelial function, 
attenuating neutrophil-mediated inflammation response in 
the myocardium, and improving contractile function [11, 
12]. Ischemic preconditioning (IPC) diminishes the effects of 
both endogenous and exogenous oxidative stress [13] and 
limits the cycle of depressive pro-inflammatory cytokine 
production [14], reducing myocardial infarct size and im-
proving cardiac function. For a summary of possible mecha-
nisms of IPC refer to Table 1. It should be mentioned that 
IPC is normally produced by subjecting the heart to three to 
five cycles of brief ischemia followed by brief reperfusion 
and is now well known to be cardioprotective against I/R-
induced injury.  
Table  1. Possible Mechanisms for the Beneficial Effects of 
Ischemic Preconditioning 
1.  Low concentrations of ROS and changes in redox state 
2.  Activation of PKC signaling 
3.  Formation of adenosine 
4.  Activation of NOS and production of NO 
5.  Activation of sarcolemmal K
+-ATP channels 
6.  Activation of mitochondrial K
+-ATP channels 
7.  Increase in antioxidant reserve 
8.  Activation of heat shock proteins 
Abbreviations: ROS, reactive oxygen species; PKC, protein kinase C; NOS, 
nitric oxide synthase; NO·, nitric oxide 
ALTERED FUNCTIONS OF SUBCELLULAR OR-
GANELLES BY ROS AND IPC 
  During ischemia there is a transition from aerobic to an-
aerobic metabolism in the heart that leads to a reduction in 
energy production depleting readily available high energy 
phosphate stores including ATP and creatine phosphate [15]. 
As a result, not only is the cardiac contractile function de-
creased, but also the function of energy-dependent ion 
pumps which cause an accumulation of metabolites and 
cations and leads to acidosis, increases the osmotic load, 
activates Ca
2+-dependent enzymes and produces ROS [15]. 
The components of the myocardial cell, which are modified 
by ROS and ultimately lead to the overall change in myocar-
dial function, include the nucleus, glycocalyx (extracellular 
matrix), cardiac myofilaments, sarcoplasmic reticulum (SR), 
sarcolemma (SL) and mitochondria of the myocardial cell. It 
is pointed out that excessive amounts of ROS, which are 
formed during the development of I/R injury, are considered 
to result in oxidative stress and produce deleterious effects 
on the myocardium. On the other hand, low concentrations 
of ROS, which are generated upon subjecting the heart to 
IPC, result in changing the redox state of cardiomyocytes 
and produce beneficial actions against I/R injury [12].  
Cardiac Nucleus 
  Modifications of the cardiac nucleus are important in IPC 
due to the observation that it undergoes changes that con-
tribute to both early phase IPC, occurring 1-3 hours after 
stimulus, and delayed phase IPC, occurring 12-24 hours after 
IPC stimulus [16]. Delayed phase IPC is caused by the 
upregulation of cardioprotective genes that occurs during the 
initial IPC stimulus which progresses to transcription regula-
tion and then translation [17]. It includes the upregulation of 
VEGF, for angiogenesis promotion, and the anti-apoptotic 
Bcl-2 protein family, to attenuate apoptosis. There have also 
been observed increases in mRNA levels for heat shock pro-
teins (HSP) 27, 70, and 89 as well as antioxidants such as 
catalase, glutathione peroxidase, and manganese superoxide 
dismutase (MnSOD) [18]. The transcription factor most ex-
tensively studied with regard to I/R injury and IPC is the 
nuclear factor -light-chain enhancer of activated B cells 
(NFB). Elevated mRNA expression and DNA binding of 
NFB has been demonstrated during IPC where, initially its 
translocation to the nucleus is increased, but then after pro-
longed I/R its activation is reduced [17, 19]. This has an ef-
fect on late-phase IPC by producing nitric oxide (NO) via 
inducible nitric oxide synthase (iNOS) upregulation [12] 
which leads to cyclooxygenase-2 activation and the produc-
tion of cytoprotective prostaglandins PGE2 and PGI2, as well 
as MnSOD and the expression of the anti-apoptotic Bcl-2 
gene family [20-22]. Observations involving Bcl-2-
associated anthanogene-1 (BAG-1) illustrate interactions 
with heat shock proteins HSC70 and HSP70 that may pro-
mote cell survival. BAG-1 is normally detected in the nu-
cleus, however following ischemia, not only was the expres-
sion of both its isoforms increased, it also increased its bind-
ing to HSC70 in rat cardiomyocytes [23]. Its expression was 
not attenuated following I/R, indicating potential cardiopro-
tective properties. In addition, when undergoing IPC, there 
has been an observed increase in the expression of the fatty 
acid transport (FAT) gene as well as genes involved with 
remodeling (fibronectin, laminin, and collagens I and II) [24, 
25]. On the other hand, oxidative stress results in the down-
regulation of genes corresponding to energy-generating 
pathways, such as fatty acid metabolism [25].  
Cardiac Glycocalyx & Myofilaments 
  Oxidative stress and IPC have measurable effects on gly-
cocalyx activities and cardiomyocyte myofilaments. The 
glycocalyx is particularly susceptible to I/R stress as it is the 
first to be exposed to injury, although preconditioning has 
also been partially effective in protecting it [26]. IPC reduces 
the cleavage of myofilament troponin I by matrix metallo-
protease 2 (MMP-2) [27] by decreasing its release and acti-
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MMP-2 has shown direct correlation with cardiac dysfunc-
tion observed in I/R injury [27, 28]. Oxidative stress, in par-
ticular stress induced by hydroxyl radicals and peroxynitrite, 
appear to cause damage in myofibrils, previously noted in 
chronic atrial fibrillation patients [29], although it may also 
cause a similar effect as a result of I/R injury. The cytoskele-
ton has also demonstrated responsiveness in IPC via ROS 
activation of p38 MAPK, which subsequently activates HSP 
27. Not only does this cause the polymerization of actin 
filaments, it also increases the stability of the contractile ap-
paratus through late-phase preconditioning [30-32].  
Sarcoplasmic Reticulum 
  The SR is a key regulator of intracellular concentration of 
Ca
2+ in cardiomyocytes. It plays an integral role in maintain-
ing cardiac contractile function as a result of its regulation of 
Ca
2+. During I/R injury, it has been observed that cytosolic 
Ca
2+ increases dramatically during initial ischemia causing 
damage to the cell and decreasing ATP [33-35]. Specifically, 
it has been noted that, even after brief episodes of ischemia, 
there are changes in SR Ca
2+ channels [36]. There have also 
been observed decreases in mRNA levels of SR Ca
2+-cycling 
proteins; however, IPC has been demonstrated to have the 
capacity to attenuate these changes by preventing intracellu-
lar Ca
2+ overload, therefore upholding normal SR function 
[37, 38]. The ROS species H2O2 has exhibited direct effects 
on SERCA (sarcoplasmic reticulum Ca
2+-stimulated-
ATPase) by decreasing its activity and causing NCX (Na
+-
Ca
2+ exchanger) to increase its activity [39]. This implies 
that redox-dependent SR Ca
2+ depletion may be partially 
affected by this reciprocal regulation of SERCA and NCX in 
rat ventricular myocytes [39]. Specifically, FeSO4/EDTA-
induced oxidative stress has shown modification of –SH 
groups, lysine, tryptophan, and tyrosine which are crucial to 
optimal Ca
2+-stimulated-ATPase activity [40]. On the other 
hand, oxidation of the –SH groups of SR ryanodine receptors 
(RyRs) have been implicated as being essential in the IPC 
process for attenuating subsequent prolonged I/R-induced 
intracellular Ca
2+-overload [41]. IPC induced cardioprotec-
tion of the SR involves mediating Ca
2+ efflux and influx be-
tween the SR and the cytoplasm of cardiomyocytes in order 
to prevent contractile dysfunction. Understanding the differ-
ences between oxidative stress induced by I/R injury from 
the beneficial effects induced by IPC on the SR could be key 
in deciphering what signaling is required to cause cardiopro-
tection.  
Sarcolemma 
  The phospholipid bilayer boundary of cardiomyocytes, 
the SL, contains a variety of receptors, as well as cation 
pumps, exchangers, and channels that are immediately sus-
ceptible to redox modification which potentially affects 
downstream signaling in the cardiomyocyte causing altera-
tion of its normal function. H2O2 has been specifically noted 
to have a bi-phasic effect on ATP-binding where the initial 
increase and then subsequent decrease of binding of ATP 
occurs in a time and concentration-dependent manner [42]. 
In addition, HOCl, a well known oxidant, was shown to in-
hibit ATP-binding; both these observations were found in SL 
membranes isolated from rat ventricular cardiomyocytes 
[42]. When porcine heart SL was treated with the xanthine-
xanthine oxidase, an oxyradical generating system, a de-
crease in Na
+-K
+-ATPase activity occurred which correlated 
partially with a decrease in its affinity. It was postulated that 
the inhibitory effect may be partially due to superoxide radi-
cal generation as singlet oxygen was found to decrease car-
diac sarcolemmal Na
+-K
+-ATPase activity [43, 44]. An in-
teresting study by Fuller et al. [45] identified an endogenous, 
stable inhibitor of cardiac-specific Na
+-K
+-ATPase that ac-
cumulates in the cell during ischemia in rat hearts. It was 
found that SL Na
+-K
+-ATPase activity rose when SL mem-
branes were purified away from the cytosol, where the in-
hibitor is located. Production of this inhibitor corresponded 
with oxidative stress induced by ischemia, indicating that 
oxidative stress has the capacity to inhibit Na
+-K
+-ATPase 
through this mechanism [43, 45, 46]. The activation of Na
+-
K
+-ATPase increases levels of Na
+, observed during ische-
mia, which can be partially explained by the presence of this 
inhibitor. Interestingly, the inhibitor was unable to be de-
tected in the cardiac effluent post-reperfusion which the 
authors postulated could be due to it remaining accumulated 
in the cytosol of the cell, or it may be inactivated immedi-
ately post-reperfusion [45]. It has also been observed that 
oxygen free radicals can physically disrupt the SL mem-
brane, causing the intracellular space to be exposed to the 
extracellular environment [9]. In addition, oxidative stress, 
caused by xanthine-xanthine oxidase, altered the activity of 
SL phospholipase C which ultimately affects downstream 
signaling, including the activation of PKC [47]. Furthermore, 
the activity of SL phospholipase D, which primarily is a part 
of the signal transduction mechanism for regulating Ca
2+ 
movements in the heart, was impaired by I/R injury via H2O2 
and HOCl by modification of its functionally critical thiol 
groups [48]. Also, the thiol groups associated with phos-
phatidylinositol 4-kinase and phosphatidylinositol 4-P-5 
kinase, required for the proper function of numerous SL pro-
teins, were impaired by ROS therefore reducing their func-
tion [49].  
  Despite the previously described ROS-induced altera-
tions of SL proteins, the one most discussed cardioprotective 
effect of preconditioning is the SL version of K
+-ATP chan-
nels (sarc K
+-ATP channels) and its comparison with mito-
chondrial K
+-ATP channels (mito K
+-ATP channels). These 
K
+-ATP channel proteins are activated by NO either from 
NO synthase (NOS) or extracellularly available NO [15]. 
Although the general consensus is that mito K
+-ATP chan-
nels play a more significant role regarding the beneficial 
effects of IPC, sarc K
+-ATP channels are important because 
of an increased vulnerability of these sites to oxidative stress 
[50]. Sarc K
+-ATP channels were initially noticed as being 
involved in IPC as they are opened when exposed to free 
radicals and have been observed to possess cytoprotective 
properties [51-54]. In a study investigating the difference 
between sarc and mito K
+-ATP channels, sarc K
+-ATP 
channels appeared to act as an effecter of preconditioning 
and were found to be important in improving functional re-
covery. This was indicated when cardioprotective effects 
induced by sarc K
+-ATP channels occurred during the stress 
period, however its activation was not required during the 
preconditioning period. In freshly isolated adult rat cardio-
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to study the effects of preconditioning [55], both sarc and 
mito K
+-ATP channels were observed to be required for car-
dioprotection against oxidative stress. In a specific mouse 
model knock-out of Kir 6.2 (the pore subunit of sarc K
+-ATP 
channels) cardioprotective effects induced by IPC were ex-
tirpated, indicating their necessity for cardioprotection in this 
model [56]. Finally, it was shown that activated sarc K
+-ATP 
channels are important in preventing cardiomyocyte apopto-
sis and mitochondrial damage during stress, as inhibition of 
these ATP channels promoted the mitochondrial death path-
way by augmenting oxidative stress-induced apoptosis. In 
addition, it was noted that mitochondrial Ca
2+ loading was 
also significantly increased upon inhibition of the sarc K
+-
ATP channel in cultured HL-1 and neonatal cardiomyocytes 
[57]. Clearly, the oxidative stress-induced alterations on the 
SL play a significant role in IPC, and despite the discussions 
comparing the significance between sarc and mito K
+-ATP 
channels, it is clear that, not only do the sarc K
+-ATP chan-
nels play an important role in IPC, but other proteins of the 
SL do as well.  
Mitochondria 
  There is an ample amount of literature discussing how 
mitochondria are involved in IPC. Mitochondria maintain the 
balance between cell life and cell apoptosis, where the key to 
its activity is its generation of ROS and free radicals within 
the cell. It appears that the majority of pathways currently 
discussed to be effective in cardioprotection converge on the 
mitochondrial permeability pore in an effort to keep it 
closed; specifically to preserve its inner membrane potential 
and reduce mitochondrial Ca
2+ to ensure uninterrupted en-
ergy production [15]. In the previously discussed study com-
paring sarc K
+-ATP and mito K
+-ATP channels [55], mito 
K
+-ATP channels acted as both an effecter of IPC and its 
trigger. Mito K
+-ATP channels were observed to be activated 
during the preconditioning period and during the exposure to 
oxidative stress. In contrast to the sarc K
+-ATP channels, 
where they were found to be important for improving func-
tional recovery, mito K
+-ATP channels were shown to have 
an effect primarily on infarct size [55]. The pharmacological 
preconditioning of the rat heart, using diazoxide, has shown 
to cause the opening of mito K
+-ATP channels and protect 
against ischemia-induced ventricular arrhythmias [58]. It was 
also demonstrated that in the mitochondrial protective path-
way, the ROS released from the mitochondria during IPC 
caused the opening of mito K
+-ATP channels upstream and 
was protective [59]. An extensive study carried out by Das 
and Sarker [60] on mito K
+-ATP channels by using nicoran-
dil or minoxidil, found that mito K
+-ATP channels have the 
potential to protect against I/R-induced arrhythmias, reduce 
myocardial infarct size, and increase cardiomyocyte survival 
in the intact anesthetized rabbit heart. The mito K
+-ATP 
channels have been observed to have properties that detect 
local oxidants resulting in decreased free radical generation. 
These sensors are likely located in the channel’s sulfonylurea 
receptor where stimulation by reactive oxygen prevents mi-
tochondrial ROS release [61]. Although some variations 
among the results are evident in different animal models, as 
well as different means of inducing IPC and/or I/R injury, it 
is clear that mito K
+-ATP channels play some role in IPC in 
protecting the heart against I/R injury. 
  The functions of mitochondria have been shown to be 
altered upon exposure of the heart to IPC including the ex-
pression of the mitochondrial antioxidant, manganese super-
oxide dismutase (MnSOD), via the formation of NFB and 
activator protein-1 (AP-1) [21]. There is also increased ATP 
production in preconditioned hearts when compared to non-
preconditioned hearts [62]. The phenomenon of “ROS-
induced ROS release” involves opening of the mitochondrial 
permeability transition pore (mPTP) by ROS to release addi-
tional ROS, validating the mitochondria as the primary 
source of ROS in the cell [5, 10]. Interestingly, IPC prevents 
the mPTP from opening so the burst of ROS does not occur 
which leads to an overall reduction of oxidative stress in the 
cell [5]. An intriguing review on the inhibitory effect of IPC 
on mitochondrial respiratory complexes has discussed how 
IPC could cause gradual activation of mitochondrial func-
tion; ultimately bypassing ROS bursts and Ca
2+ overload 
[63]. Complex I (NADH ubiquinone oxidoreductase) repre-
sents the electron entry into the mitochondria and is a major 
site of ROS generation [64, 65]. The regulation of 
NADH/NAD
+ redox balance was shown to influence mPTP 
opening where an increase in NADH/NAD
+ ratio inhibited 
its opening [63, 66]. IPC and NO also inhibited the activity 
of Complex I thus minimizing ROS generation [63]. Com-
plex I was reversibly inhibited by S-nitrosation, a potential 
mechanism for NO-dependent mitochondria respiratory 
chain control [67]; inhibition of this complex by as little as 
25% has demonstrated significant inhibition of the respira-
tory chain, as it is the entry point for electrons [67, 68]. 
Complex II (succinate dehydrogenase) has been connected to 
mito K
+-ATP channel function where inhibition of complex 
II was found to open mito K
+-ATP channels and result in 
cardioprotection [63, 69]. Complex III (cytochrome bc1 
complex) is another site of ROS formation in the electron 
transport chain, where its inhibition is a function of its own 
ROS generation [63]. Unfortunately, how this complex is 
affected by IPC is currently unknown. Complex IV (cyto-
chrome c oxidase) has been shown to be inhibited by NO·, 
which is released during I/R [63, 70]. Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was also inhibited by 
endogenously derived nitrolipids generated during IPC [71, 
72]. This causes the accumulation of fructose-1,6-
bisphosphate (F-1,6-BP) which has been observed to im-
prove glycolytic flux and functional recovery in post-
ischemic myocardium [73]. In addition, the quantity of lac-
tate, the final product of anaerobic glycolysis that occurs 
during ischemia, was observed to be nine-fold less in pre-
conditioned hearts compared to non-preconditioned hearts 
[73]. This demonstrates the ability of IPC to inhibit glycoly-
sis resulting in the prevention of acidosis [64]. As a final 
note, cytosolic to mitochondrial relocation of hexokinase has 
been shown to occur in IPC, moderating cytochrome c re-
lease and ROS production [74, 75].  
ENDOGENOUS CARDIOPROTECTIVE INTERVEN-
TIONS 
  A number of proteins and molecules are involved in car-
dioprotection and are influenced by the redox state induced 
by IPC. The majority of these proteins had, at some point, 
been involved following the release of small amounts of 
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heart-derived cell line) cells can induce the production of the 
cyclooxygenase-2 (COX-2) protein [76]. Although COX-2 is 
upregulated in oxidative stress-induced injury and apoptosis, 
it was found to be cardioprotective upon the conversion of 
arachidonic acid to PGH2. It is pointed out that PGH2 is fur-
ther derived into cytoprotective prostanoids, PGE2 and PGI2, 
which were found to attenuate stunning and reduce infarct 
size after I/R [77-80]. PKC has also been attributed to IPC 
as it is activated by low concentrations of oxygen radicals 
and has been observed to be involved in IPC cardioprotec-
tion [81-84]. The activation of phospholipase (PL) C and D 
causes the subsequent release of diacylglycerol, a PKC acti-
vator, suggesting PKC as a molecule involved in IPC [15]. 
PLD has been implied to evoke a cell-survival response upon 
exposure to low concentrations of oxidants for a brief length 
of time [85]. In particular, PLD 2 has been noted to have 
elevated activity when reperfusion occurs briefly after a brief 
period of ischemic insult to the heart, but its activity is re-
duced during prolonged reperfusion [86]. Preconditioning 
has also been illustrated as being promoted by various recep-
tors such as adenosine, adrenergic, bradykinin, and opiod 
receptors as well as limiting the cycling of depressive pro-
inflammatory cytokine production [14, 87]. Thioredoxin, a 
sulfide reductase, plays a part in maintaining the redox activ-
ity inside the cell whose activity is propagated by oxidative 
stress [88, 89]. It has been shown to be instrumental in 
transmitting the survival signal in ischemic myocardium 
[90]; however, it is down-regulated after I/R injury [91]. 
Interestingly, post-IPC appears to cause an upregulation in 
thioredoxin, and, in transgenic mouse hearts where there are 
extra copies of its gene, the cardiomyocytes were resistant to 
apoptosis [91]. 
  Cardiomyocytes have a few antioxidants that are able to 
protect the cell from oxidative stress. It is important to pro-
tect the cell from oxidative stress, both intracellularly and 
extracellularly, and the first endogenous antioxidant to en-
counter ROS is extracellular superoxide dismutase (E-SOD). 
There are also two additional isozymes, the copper/zinc-
containing SOD (CuZn-SOD) localized in the cytosol and 
the previously described Mn-SOD, present in the mitochon-
dria [92]. These scavenging proteins have also been found to 
be upregulated after delayed preconditioning [18, 93]. The 
effects of SOD in cardioprotection are slightly controversial 
as it has been shown that neither IPC nor I/R affect its activ-
ity in cardiomyocytes [94]. It has been suggested that anti-
oxidant activities may only be altered by episodes of intense 
myocardial I/R injury [94]. Extracellularly, IPC causes the 
activation of a SOD-like anti-O2· mechanism reducing the 
oxyradical burst [94], and protecting the glycocalyx [26]. 
Despite the uncertainty regarding the beneficial effect of IPC 
on SOD levels, other antioxidants have been observed to be 
upregulated during IPC. This includes mitochondrial uncou-
pling proteins (UCPs) 2 and 3, where their upregulation is 
inversely proportional to infarct size in preconditioned hearts 
[95]. The preconditioned mitochondria were found to pro-
duce less hydrogen peroxide compared to control. These 
UCPs are activated by ROS signaling and are thought to pro-
tect the cell from excessive ROS generation in an automatic 
regulatory forward way [96, 97] which would explain their 
effectiveness in reducing infarct size in preconditioned 
hearts. Glutathione (GSH) is an intracellular antioxidant that 
scavenges ·OH, HOCl, peroxynitrate and O2· radicals during 
times of oxidative stress [98]. IPC has been found to pre-
serve the levels of GSH in isolated rabbit hearts [13, 98] 
which partially explains the reduced amount of oxidative 
damage sustained by preconditioned hearts. Vitamin C, also 
known as ascorbic acid, is another endogenous antioxidant 
that, not only has been shown to react with ROS in vivo, but 
is able to remain in cells for long periods [99, 100]. Vitamin 
C has the ability to protect against H2O2-induced cell injury 
in H9c2 cells [99] and has been shown to be surprisingly 
effective in protecting plasma lipoproteins from aqueous 
peroxy radical damage [101]. There is still some debate as to 
how, or even if, antioxidants play a role in IPC, as literature 
indicates increases [102], decreases [103, 104], or lack of 
changes [105, 106], in antioxidant levels. However, it is im-
portant to keep in mind that endogenous antioxidants are 
present in myocardial cells and varying experimental proto-
cols involving different species, methods of inducing IPC 
and/or I/R injury, and the specific antioxidants studied make 
this area of research still a mystery waiting to be solved.  
ROS CAUSES CARDIOPROTECTION 
  Although ROS were originally viewed as having only 
detrimental impacts upon cellular function, there is now evi-
dence that certain levels and types of ROS may be beneficial 
and possibly contribute to cardioprotection in IPC myocar-
dium. When considering free radicals, there has been an ob-
served “radical threshold” where, below this threshold, car-
diac function is able to recover, however above this thresh-
old recovery is not possible [107]. The catecholamine 
adrenaline (ADR) is known to evoke a pro-oxidant signal 
which causes the translocation of protective transcription 
factors HSF-1 and NFB. Interestingly, in isolated rat car-
diomyocytes, the pro-oxidant signal from ADR also de-
creases proteosome activity, which can be recovered upon 
the addition of the ROS scavenger, tiron [108]. It has also 
been reported that an increase in endogenous ascorbyl free 
radical formation may improve functional recovery despite 
its contribution to oxidative stress [109].  
Hyperoxia 
The utilization of new technology, such as electron par-
amagnetic resonance (EPR) paired with oxygen sensitive 
probes, such as LiPc, allow scientists to measure specific 
PO2/redox status in vivo [110], and Doppler flow measure-
ment allows for the investigation of changes in oxygen con-
sumption and tissue oxygenation in vivo [111]. After I/R, 
myocardial tissue reveals hyperoxygenation [112] suggesting 
the possibility that I/R causes the myocardium to utilize less 
oxygen [111]. It has been shown that ROS and reactive ni-
trogen species (RNS), formed during I/R, inhibited mito-
chondrial oxygen consumption [112], however, IPC attenu-
ated hyperoxygenation due to observed higher blood flow 
and lower PO2 and the possible preservation of higher levels 
of O2 utilization [111]. I/R injury was also shown to occur in 
the brain where the treatment of normobaric hyperoxia (95% 
O2 with 5% CO2) immediately after I/R was found to reduce 
the infarction volume and improve neurological function 
close to pre-ischemic levels [113]. It was hypothesized that 
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ischemia, as there was no increase in oxidative stress when 
normobaric hyperoxia treatment was applied during focal 
cerebral I/R [113, 114]. Hyperoxia treatment has also been 
studied in rat hearts [115, 116]. In one study, mechanically 
ventilated rats were exposed to hyperoxia for 30 minutes 
before the hearts were isolated and subjected to 30 min of 
ischemia followed by 2 hr of reperfusion. Hyperoxia was 
found to improve cardiovascular function, left ventricular 
end-diastolic pressure, left ventricular end-developed pres-
sure, and reduce infarct size [115]. Another study reported 
similar results when inducing hyperoxic preconditioning in 
addition to reductions in cytochrome-c release and DNA 
fragmentation which suggest that hyperoxia increases car-
diomyocyte tolerance by ROS activation of NFB [116]. In 
an open-chest rabbit model of I/R, the exposure of the heart 
to 100% oxygen during ischemia-only, reperfusion-only, and 
I/R resulted in smaller infarct sizes as well [117]. It is thus 
evident that low concentrations of ROS play a role in IPC 
that allow for cardioprotection where alterations in the sub-
cellular organelles may not occur to the point where drastic 
changes occur that impair cardiac function.  
Nitric Oxide and Nitric Oxide Synthases 
  Endogenous NO and NOS - originally thought of as 
sources of oxidative stress on cardiomyocytes - have proper-
ties that contribute to IPC and cardioprotection. The excess 
O2-· caused by I/R injury is scavenged by NO donors, thus 
protecting the myocardium from I/R injury [118, 119]. In 
newborn rat cardiomyocytes, treatment with an NO donor 
(sodium nitroprusside) can activate SERCA2a causing an 
increase in Ca
2+ uptake and subsequently preventing cytoso-
lic Ca
2+ upload [120]. NO can also contribute to the S-
nitrosation whose primary target is Complex I of the electron 
transport chain in the mitochondria, causing its decrease in 
activity which occurs exclusively in I/R [121]. The modifica-
tion of cysteine residues by NO· has been hypothesized to 
form a “molecular cap” that prevents further oxidation of 
thiols by ROS, resulting in the regulation of ROS formation 
from mitochondria and caspase-3 apoptotic activity [122- 
124]. NOS has been implicated in preconditioning and car-
dioprotection, as it was observed to decrease infarct size and 
increase the recovery of left ventricular diastolic pressure; 
there was a four-fold increase of Hsp90 association with 
eNOS and increases in eNOS itself in the myocardium [125]. 
eNOS has demonstrated possessing cardioprotective proper-
ties and its involvement in preconditioning has been shown, 
in a variety of studies, to recruit endothelial progenitor cells 
(EPC) that express potentially cardioprotective cytokines 
including NOS isoforms [126]. The complex formed be-
tween eNOS and HSP90 allows for phosphorylation en-
hancement of eNOS via Akt, amplifies NO release, and in-
creases production of cyclic guanosine monosphophate [127-
129]. Protection has been implied as being partially depend-
ent on this HSP90/eNOS association enhancement and the 
resulting NO release [130]. IPC has been shown to preserve 
the function eNOS as well, hastening endothelial recovery 
and function [131].  
CONCLUSION 
  In I/R, oxidative stress leads to cardiac dysfunction 
which can be attenuated by IPC. ROS, the cause of oxidative 
stress, alter the functions of various subcellular organelles in 
both I/R injury and IPC [12]. The nucleus is shown to 
upregulate a slew of cardioprotective genes that have shown 
effects in late-phase IPC [17, 25], largely as a result of in-
creased NFB action [17]. IPC reduces the effects of MMP-2 
ultimately protecting the glycocalyx and increases the stabil-
ity of contractile myofilaments [27, 30-32]. SR, the principal 
Ca
2+ regulator of the cell responsible for maintaining con-
tractile function, undergoes alterations of its Ca
2+ channels, 
including SERCA, NCX, and RyRs [36, 39, 41] which are 
modified in I/R injury and preserved by IPC. Oxidative 
stress has also shown to have an inhibitory effect on SL Na
+-
K
+-ATPase [43-45] and to physically disrupt the phosphol-
ipid bilayer [9]. With regards to IPC, the most effective pro-
tection of the SL is the activation of sarc K
+-ATP channels, 
however, the extent of its effect compared to mito K
+-ATP 
channels is still a debatable topic. Both these K
+-ATP chan-
nels have been shown to be effective in different animal 
models where the mitochondrial isoform acts as an effecter 
and a trigger, and the SL isoform is an effecter [55]. The 
importance of the SL isoform is emphasized by the studies of 
Kir 6.2 KO mice where the missing pore subunit of the sarc 
K
+-ATP channel prevented protection of I/R injury post-IPC 
[56]. Mitochondria are the main source of free radicals in the 
cell, and, coupled with their “ROS-induced ROS release” 
mechanism, are not only affected by oxidative stress but in-
cur further damage upon the cell [5, 10]. IPC has been 
shown to inhibit the electron transport chain, particularly at 
the electron entry point of Complex I [67, 68], suggesting 
that a low amount of ROS triggers an anti-apoptotic protec-
tive measure whereas high amounts of ROS promote mito-
chondrial release of pro-apoptotic factors for the develop-
ment of oxidative stress. 
  Several endogenous protective interventions have also 
been demonstrated to be activated when triggered by IPC. 
These include the upregulation of COX-2 [76] and activation 
of the PKC pathway [82, 83]. Interestingly, upon low con-
centrations of oxidant exposure, PLD signals for cell sur-
vival are generated during IPC [85]. Thioreduxin, a survival 
signal transmitter active in ischemic myocardium, also has 
increased activity in IPC [90]. Despite the existing debate 
regarding the effectiveness of different antioxidants in IPC, 
eSOD [26, 92], mitochondrial UCPs 2 and 3 [95], GSH [98], 
and vitamin C [101] still seem to be involved. Although 
these antioxidants become more active, there is still need for 
further exploration on their effects. Oxidative stress itself has 
demonstrated cardioprotective properties and involvement in 
IPC. The pro-oxidant signal of ADR increases the transloca-
tion of protective transcription factors [108], whereas hyper-
oxia has also been shown to be protective in both rat and 
rabbit models of IPC [115-117]. In IPC and cardioprotection 
NOS, especially eNOS, has shown effectiveness in attenuat-
ing oxidative damage, particularly when it forms a complex 
with HSP90 [125-129]. An outline of proposed pathways 
differentiating the two phases of preconditioning is displayed 
in Fig. (2). Most of the work on IPC showing beneficial ef-
fects for the recovery of cardiac function preceding I/R in-
jury has been carried out in the isolated heart preparation. 
However, this procedure should be extended to the clinical 
setting where IPC should be conducted by 3 to 5 cycles of 



















Fig. (2). Outline of proposed pathways of redox induced early and 
late phases of ischemic preconditioning. Abbreviations: I/R, ische-
mia-reperfusion; ROS, reactive oxygen species; NOS, nitric oxide 
synthase; PKC, protein kinase C. 
 
clamping and releasing of the aorta before carrying out coro-
nary bypass surgery, angioplasty, heart transplantation, or 
thrombolytic therapy. IPC can cause resistance to oxidative 
damage by altering the redox state of cardiomyocytes and 
can be protective by increasing the resistance of subcellular 
organelles to ROS modifications.  
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